drugset / Trial / NCT00002362
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
Treatment
Summary
This study will look at whether emtricitabine is as safe and effective as abacavir (ABC) when taken with stavudine (d4T) and efavirenz (EFV) in patients who have never taken anti-HIV drugs.
Timeline
- Start
- 1999-08
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abacavir | Other / unclassified | — | — |
| Subject | emtricitabine | Other / unclassified | — | — |
| Background | Efavirenz | Other / unclassified | — | — |
| Background | Stavudine | Other / unclassified | — | — |